Daewoong to work on digital twin bio manufacturing tech under state R&D project < Pharma < Article
Daewoong said that it has been selected for a national research and development (R&D) project organized by the Ministry of Trade, Industry and Energy to advance digital twin-based…
The convergence of AI technologies and human Expertise in pharma R&D
The biopharma Industry has undergone a Digital Transformation, leveraging AI, automation and patient-centric technologies to significantly accelerate R&D timelines and improve productivity. This digital-first approach, combined with strategic collaborations and…
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March…
Innocan Pharma Provides its Annual “State of Research and Development” Update for 2024
HERZLIYA, Israel and CALGARY, Alberta, Dec. 12, 2024 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical technology company focusing on developing…
Shanghai’s science ecosystem powers pharma giants’ innovation
HelloRF A complete technology innovation investment system will gradually take shape in Shanghai, facilitating early-stage technology incubation and industrial integration. Top pharmaceutical companies are banking on Shanghai’s strong science and…